Viewing Study NCT00693433


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2026-01-07 @ 6:43 PM
Study NCT ID: NCT00693433
Status: COMPLETED
Last Update Posted: 2015-12-04
First Post: 2008-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Multiple Myeloma View
None Stage I Multiple Myeloma View
None Stage II Multiple Myeloma View
None Stage III Multiple Myeloma View
Keywords: